Fontan Udenafil Exercise Longitudinal Assessment Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of adolescent subjects who have undergone the Fontan procedure.
Epistemonikos ID: e39eadf337d76516cad2f047088a714b0cb9da58
First added on: May 12, 2024